Europe Vascular Access Device Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Europe Vascular Access Device Market is Segmented by Device Type (Central Vascular Access Devices and Peripheral Vascular Access Devices), Application (Medication or Drug Administration, Fluid and Nutrition Administration, and More), End User (Hospitals & Clinics, and More), Material (Polyurethane, Silicone, and Others), and Geography (Germany, and More). The Market and Forecasts are Provided in Terms of Value (USD).

Europe Vascular Access Device Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Europe Vascular Access Device Market with other markets in Healthcare Industry

Europe Vascular Access Device Market Analysis by Mordor Intelligence

The Europe vascular access devices market stands at USD 1.64 billion in 2025 and is projected to reach USD 2.29 billion by 2030, registering a 6.91% CAGR over the forecast period. An increasingly older population, tighter infection-prevention standards, and material-science advances are combining to shift clinical practice toward safer, longer-dwelling catheters and wider use of peripheral insertion techniques. Hospitals augment demand as chronic-disease admissions rise, while home-infusion programs extend use beyond traditional facilities. EU Medical Device Regulation (EU-MDR) enforcement accelerates the replacement of legacy products with antimicrobial-coated or sensor-equipped alternatives, and Germany’s sizable procedural volume anchors regional revenues even as France posts the fastest growth. Polyurethane remains prevalent, yet silicone and next-generation hydrophilic polymers gain traction as suppliers hedge against PFAS restrictions and supply-chain volatility.

Key Report Takeaways

  • By device type, central vascular access systems led with 55.31% revenue share in 2024, while peripheral devices are forecast to expand at a 7.56% CAGR through 2030 within the Europe vascular access devices market.  
  • By application, medication administration accounted for 38.41% of the Europe vascular access devices market size in 2024, whereas diagnostics and testing are advancing at a 7.61% CAGR to 2030.  
  • By end user, hospitals and clinics held 52.89% of the Europe vascular access devices market share in 2024, but ambulatory surgery centers are projected to grow at a 7.77% CAGR over the same horizon.  
  • By material, polyurethane dominated with 47.98% share in 2024; silicone catheters record the swiftest expansion at a 7.89% CAGR.  
  • By geography, Germany captured 40.21% of regional revenues in 2024, while France is on course for a 7.84% CAGR between 2025 and 2030.

Segment Analysis

By Device Type: Central Dominance Faces Peripheral Innovation

Central lines continued to account for 55.31% of revenue in 2024 as oncologists and critical-care teams rely on ports and tunneled catheters for multidose regimens. At the same time, peripheral alternatives recorded the highest 7.56% CAGR, reflecting clinician preference for lower-risk insertion sites and growing ultrasound-guided competency. New hydrophilic midline formats reduce thrombus formation by 96%, and antimicrobial polyurethane hubs exhibit 99.998% lower bacterial adhesion than standard plastics. Vendors are integrating blood-draw valves into peripherally inserted central catheters to support lab sampling without additional sticks, a feature valued in pediatric wards.

Integrated short peripheral cannulas increasingly carry closed systems that limit exposure, extending dwell times beyond 96 hours. Mid-sized hospitals adopt device-agility protocols that graduate patients from short cannulas to midlines rather than directly to central lines, tightening the cycle time between admissions and discharge. As a result, purchasing committees reevaluate the optimal mix of catheter SKUs, buoying unit shipments of peripheral devices within the Europe vascular access devices market. However, central implants remain irreplaceable for power-injection imaging and vesicant therapy, ensuring sustained baseline demand.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Application: Medication Leadership Challenged by Diagnostic Growth

Medication delivery absorbed 38.41% of the Europe vascular access devices market size in 2024, driven by continual antimicrobial and chemotherapy infusion. Diagnostics and testing, though smaller, accelerate at a 7.61% CAGR to 2030 as point-of-care protocols mandate repeat blood draws. Manufacturers therefore package needle-free connectors with sample-optimized flow paths, addressing contamination risks. Sensor-enabled cannulas detect occlusions in real time, improving sample integrity and curtailing repeat sticks that can inflate consumable costs.

Blood-product transfusion lines benefit from closed-loop identification systems that synchronize with hospital information technology, cutting mismatch errors. Nutrition-delivery applications remain steady amid an aging patient population requiring long-term parenteral support in nursing facilities. Many facilities now update flush policy every 12 hours, lifting saline and heparin lock solution sales. With wider adoption of dual-lumen catheters in oncology, the Europe vascular access devices market positions itself to capture both therapeutic and diagnostic revenues in a single procedure.

By End User: Hospital Dominance Yields to Ambulatory Expansion

Hospitals still represented 52.89% of the Europe vascular access devices market share in 2024 because intensive care, oncology, and interventional radiology departments collectively generate high-value procedures. Yet ambulatory surgery centers are pacing a 7.77% CAGR as minimally invasive procedures migrate to day-case settings. Outpatient centers prefer midlines and power-injectable ports that support rapid turnover, prompting bulk purchases of pre-assembled kits that shorten prep time.

Home-health programs, backed by insurers seeking to decongest hospital beds, deploy portable infusion pumps paired with silicone midlines. Community-based nurses receive remote alerts if flow deviates from baseline, reducing unplanned emergency visits. Specialty dialysis clinics invest in tunneled catheters with antimicrobial cuffs to lessen infection readmissions. These patterns diversify demand channels while enhancing procedural consistency, reinforcing overall volume growth for the Europe vascular access devices market.

Europe Vascular Access Device Market: Market Share by End User
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Material: Polyurethane Prevalence Challenged by Silicone Innovation

Polyurethane captured 47.98% of 2024 revenues, favored for tensile strength and manufacturing familiarity. However, EU proposals to curtail PFAS usage stir conversion toward silicone and novel copolymers. Silicone catheters, expanding at a 7.89% CAGR, exhibit reduced thrombogenicity and ease of insertion in tortuous vessels. Hydrophilic surface treatments bonded to silicone further lower protein adsorption, and antimicrobial silver-ion impregnations meet infection-control targets without systemic antibiotic exposure.

PTFE shortages during 2024 prompted leading suppliers to insource extrusion lines and qualify alternative grades from Asian producers. Concurrently, research groups pioneer bio-resorbable polymers for temporary arteriovenous shunts, opening a new premium tier. As notified bodies scrutinize extractables data, materials that generate fewer leachables secure faster conformity assessment, indirectly accelerating market entry within the Europe vascular access devices market.

Geography Analysis

Germany anchored 40.21% of regional revenue in 2024 on the back of dense hospital networks, high diagnostic throughput, and early reimbursement for antimicrobial innovations. Federal infection-control mandates reimburse coated lines at a premium, and local manufacturers collaborate with Fraunhofer institutes to co-develop PFAS-free extrusion processes, broadening product portfolios. Continuous medical-education curricula ensure that vascular access insertion is ultrasound-guided across most tertiary centers, keeping complication rates comparatively low and sustaining predictable re-ordering cycles.

France posted the fastest 7.84% CAGR by modernizing outpatient oncology services and widening access to day-hospital infusion suites. National surveillance covering 55,000 catheters confirmed a downward trend in bloodstream infections when silver-ion cuffs were systematically deployed. The outcomes convinced regional procurement groups to bundle coated ports with dressing kits, creating multi-year supply contracts that favor vendors able to guarantee EU-MDR certificates.

The United Kingdom leverages National Health Service (NHS) technology funds to trial sensor-equipped midlines that alert clinicians to early infiltration, cutting extravasation incidents by 23%. Italy and Spain prioritize pediatric access improvement programs financed through EU cohesion funds, while Nordic countries integrate telehealth monitoring for patients discharged with peripherally inserted central catheters. Central-Eastern European markets align local legislation with EU-MDR, facilitating imports yet facing limited notified-body capacity; hospitals therefore rely on larger multinationals that already possess certificates, indirectly concentrating sales among top players in the Europe vascular access devices market.

Competitive Landscape

Market leadership tilts toward multinationals that maintain comprehensive EU-MDR technical files and supported clinical-evidence dossiers. Becton Dickinson, Teleflex, and Cook Medical collectively supply a broad portfolio spanning short PIVCs, PICCs, ports, and antimicrobial coatings. Mid-tier firms emphasize niche specializations such as pediatric-sized silicone catheters or hydrophilic biomaterials. Access Vascular’s MIMIX platform exemplifies material differentiation by offering near-zero bacterial adhesion, earning adoption in infection-prone oncology wards.

Strategic activity centers on vertical integration and portfolio broadening. Teleflex’s EUR 760 million purchase of Biotronik’s vascular intervention arm in February 2025 broadens its access to drug-coated balloons and stents that complement catheter lines. BD released an intraosseous access system in October 2024, filling gaps for emergency scenarios where peripheral cannulation fails. Vendors are also entering distribution alliances with digital-health startups to embed flow-monitoring chips that transmit via Bluetooth Low Energy to nurse dashboards. This convergence of hardware and software enhances switching costs and underpins long-term contracts across the Europe vascular access devices market.

Investment in manufacturing resilience rises as suppliers localize extrusion and sterilization capacity inside the EU to hedge against raw-material interruptions and shipping delays. Firms adopting silicone or PFAS-free substitutes file new patents on surface-modification chemistries, signaling an innovation wave that could reset brand hierarchies. Competitive intensity remains moderate, yet EU-MDR attrition of smaller players lifts combined top-five share above 70%, pointing to consolidation momentum.

Europe Vascular Access Device Industry Leaders

  1. B.Braun Melsungen Ag

  2. Becton, Dickinson and Company

  3. Teleflex Incorporated

  4. Baxter International Inc.

  5. NIPRO Medical Corporation

  6. *Disclaimer: Major Players sorted in no particular order
Europe Vascular Access Device Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • February 2025: Teleflex announced acquisition of Biotronik’s Vascular Intervention business for approximately EUR 760 million, expanding its interventional portfolio with drug-coated balloons and stents.
  • January 2025: Xeltis completed enrolment in its EU pivotal trial for aXess, a restorative vascular access conduit for adults with end-stage renal disease, across 22 European centers.
  • December 2024: Teleflex launched the Pressure Injectable Arrowg+ard Blue Plus MSB Procedure Kit in EMEA, featuring a full-spectrum antimicrobial central venous catheter.
  • October 2024: BD introduced the BD Intraosseous Vascular Access System for rapid fluid or medication delivery when IV access is difficult.

Table of Contents for Europe Vascular Access Device Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing prevalence of chronic diseases
    • 4.2.2 Rising number of chemotherapy procedures & high hospitalization
    • 4.2.3 Increasing pediatric utilization of VADs
    • 4.2.4 Shift toward home-infusion therapies in Europe
    • 4.2.5 EU-MDR-driven adoption of antimicrobial-coated catheters
    • 4.2.6 Pilots of sensor-enabled catheters for IV infiltration alerts
  • 4.3 Market Restraints
    • 4.3.1 Risks & complications associated with catheter use
    • 4.3.2 Stringent regulations & product recalls
    • 4.3.3 Polyurethane supply-chain vulnerability
    • 4.3.4 Growth of needle-free connectors cannibalising short PIVCs
  • 4.4 Regulatory Landscape
  • 4.5 Technological Outlook
  • 4.6 Porters Five Forces Analysis
    • 4.6.1 Threat of New Entrants
    • 4.6.2 Bargaining Power of Buyers/Consumers
    • 4.6.3 Bargaining Power of Suppliers
    • 4.6.4 Threat of Substitute Products
    • 4.6.5 Intensity of Competitive Rivalry

5. Market Size & Growth Forecasts (Value, USD)

  • 5.1 By Device Type
    • 5.1.1 Central Vascular Access Devices
    • 5.1.1.1 Peripherally-Inserted Central Catheters (PICCs)
    • 5.1.1.2 Non-tunnelled Catheters
    • 5.1.1.3 Tunnelled Catheters
    • 5.1.1.4 Other Central Vascular Access Devices
    • 5.1.2 Peripheral Vascular Access Devices
    • 5.1.2.1 Peripheral IV Catheters (PIVC)
    • 5.1.2.2 Midline Catheters
    • 5.1.2.3 Other Peripheral Vascular Access Devices
  • 5.2 By Application
    • 5.2.1 Medication or Drug Administration
    • 5.2.2 Fluid and Nutrition Administration
    • 5.2.3 Blood and Blood-Product Transfusion
    • 5.2.4 Diagnostics and Testing
    • 5.2.5 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospitals & Clinics
    • 5.3.2 Ambulatory Surgery Centers
    • 5.3.3 Others
  • 5.4 By Material
    • 5.4.1 Polyurethane
    • 5.4.2 Silicone
    • 5.4.3 Others
  • 5.5 By Geography
    • 5.5.1 Germany
    • 5.5.2 United Kingdom
    • 5.5.3 France
    • 5.5.4 Italy
    • 5.5.5 Spain
    • 5.5.6 Rest of Europe

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
    • 6.3.1 Becton, Dickinson and Company
    • 6.3.2 B. Braun SE
    • 6.3.3 Baxter International
    • 6.3.4 ICU Medical Inc.
    • 6.3.5 Teleflex Incorporated
    • 6.3.6 Edwards Lifesciences Corporation
    • 6.3.7 AngioDynamics
    • 6.3.8 Terumo Corporation
    • 6.3.9 Nipro Corporation
    • 6.3.10 Medtronic plc
    • 6.3.11 Fresenius Medical Care AG & Co. KGaA
    • 6.3.12 Vygon SA
    • 6.3.13 VascuLogic
    • 6.3.14 Access Scientific LLC
    • 6.3.15 Poly Medicure Ltd.
    • 6.3.16 Merit Medical Systems
    • 6.3.17 Penumbra, Inc
    • 6.3.18 Cook Medical
    • 6.3.19 Vantex (Vascular Technology Inc.)
    • 6.3.20 GBUK Group
    • 6.3.21 VasoVet

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Europe Vascular Access Device Market Report Scope

Vascular access devices (VADs) are inserted into the veins for diagnostic and therapeutic reasons, such as blood sampling, central venous pressure readings, administration of medication, fluids, total parenteral nutrition (TPN), and blood transfusions. These are inserted peripherally or centrally. 

The Europe vascular access device market is segmented by device type (central vascular access devices (peripherally inserted central catheters, percutaneous non-tunneled catheters, and other central vascular access devices) and peripheral vascular access devices (peripheral catheters, midline catheters, and other peripheral vascular access devices))), by application (administration of drugs, administration of fluid and nutrition, diagnostics and testing, and other applications), by end-user (hospitals and clinics, diagnostic centers and other end-users) and geography (Germany, United Kingdom, France, Italy, Spain, and Rest of Europe). 

The report offers the value (in USD) for the above segments.

By Device Type Central Vascular Access Devices Peripherally-Inserted Central Catheters (PICCs)
Non-tunnelled Catheters
Tunnelled Catheters
Other Central Vascular Access Devices
Peripheral Vascular Access Devices Peripheral IV Catheters (PIVC)
Midline Catheters
Other Peripheral Vascular Access Devices
By Application Medication or Drug Administration
Fluid and Nutrition Administration
Blood and Blood-Product Transfusion
Diagnostics and Testing
Other Applications
By End User Hospitals & Clinics
Ambulatory Surgery Centers
Others
By Material Polyurethane
Silicone
Others
By Geography Germany
United Kingdom
France
Italy
Spain
Rest of Europe
By Device Type
Central Vascular Access Devices Peripherally-Inserted Central Catheters (PICCs)
Non-tunnelled Catheters
Tunnelled Catheters
Other Central Vascular Access Devices
Peripheral Vascular Access Devices Peripheral IV Catheters (PIVC)
Midline Catheters
Other Peripheral Vascular Access Devices
By Application
Medication or Drug Administration
Fluid and Nutrition Administration
Blood and Blood-Product Transfusion
Diagnostics and Testing
Other Applications
By End User
Hospitals & Clinics
Ambulatory Surgery Centers
Others
By Material
Polyurethane
Silicone
Others
By Geography
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the current size of the Europe vascular access devices market?

The market is valued at USD 1.64 billion in 2025 and is forecast to reach USD 2.29 billion by 2030.

Which device type holds the largest share in Europe?

Central vascular access systems lead with 55.31% revenue share, although peripheral devices are growing the fastest.

How does EU-MDR affect manufacturers?

Stricter documentation and limited notified-body capacity delay certifications, raising compliance costs and favoring well-resourced companies.

Which material is gaining ground against polyurethane catheters?

Silicone is expanding at a 7.89% CAGR due to its biocompatibility and resilience to upcoming PFAS restrictions.

Why are ambulatory surgery centers important to future growth?

Outpatient facilities perform more minimally invasive procedures, driving a 7.77% CAGR for vascular access devices suitable for same-day care.

Page last updated on: June 18, 2025

Europe Vascular Access Device Market Report Snapshots